Abstract
Twice-yearly lenacapavir injections provide 100% protection in study in African women.
MeSH terms
-
Anti-HIV Agents* / administration & dosage
-
Anti-HIV Agents* / therapeutic use
-
Clinical Trials as Topic
-
Female
-
HIV Infections* / prevention & control
-
Humans
-
Pre-Exposure Prophylaxis* / methods
-
South Africa